156 related articles for article (PubMed ID: 32916470)
21. L-type amino acid transporter 1 (LAT1): a new therapeutic target for canine mammary gland tumour.
Fukumoto S; Hanazono K; Komatsu T; Ueno H; Kadosawa T; Iwano H; Uchide T
Vet J; 2013 Oct; 198(1):164-9. PubMed ID: 23896327
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of 125I-3-iodo-alpha-methyl-L-tyrosine uptake in Chinese hamster ovary (CHO-K1) cells by tyrosine esters.
Shikano N; Ogura M; Sagara J; Nakajima S; Kobayashi M; Baba T; Yamaguchi N; Iwamura Y; Kubota N; Kawai K
Nucl Med Biol; 2010 Feb; 37(2):189-96. PubMed ID: 20152718
[TBL] [Abstract][Full Text] [Related]
23. System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET).
Habermeier A; Graf J; Sandhöfer BF; Boissel JP; Roesch F; Closs EI
Amino Acids; 2015 Feb; 47(2):335-44. PubMed ID: 25385314
[TBL] [Abstract][Full Text] [Related]
24. PET Imaging of L-Type Amino Acid Transporter (LAT1) and Cystine-Glutamate Antiporter (x
Krys D; Mattingly S; Glubrecht D; Wuest M; Wuest F
Mol Imaging Biol; 2020 Dec; 22(6):1562-1571. PubMed ID: 32789819
[TBL] [Abstract][Full Text] [Related]
25. L-type amino acid transporter 1 utilizing prodrugs: How to achieve effective brain delivery and low systemic exposure of drugs.
Puris E; Gynther M; Huttunen J; Petsalo A; Huttunen KM
J Control Release; 2017 Sep; 261():93-104. PubMed ID: 28662899
[TBL] [Abstract][Full Text] [Related]
26. Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics.
Kanai Y
Pharmacol Ther; 2022 Feb; 230():107964. PubMed ID: 34390745
[TBL] [Abstract][Full Text] [Related]
27. Polymeric ligands comprising sulfur-containing amino acids for targeting tumor-associated amino acid transporters.
Guo H; Xu W; Nomoto T; Kanamori K; Voon YM; Honda Y; Yamada N; Takemoto H; Matsui M; Nishiyama N
Biomaterials; 2023 Feb; 293():121987. PubMed ID: 36584445
[TBL] [Abstract][Full Text] [Related]
28. Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors.
Fan X; Ross DD; Arakawa H; Ganapathy V; Tamai I; Nakanishi T
Biochem Pharmacol; 2010 Sep; 80(6):811-8. PubMed ID: 20510678
[TBL] [Abstract][Full Text] [Related]
29. Development of Sesamol Carbamate-L-Phenylalanine Prodrug Targeting L-Type Amino Acid Transporter1 (LAT1) as a Potential Antiproliferative Agent against Melanoma.
Srisongkram T; Bahrami K; Järvinen J; Timonen J; Rautio J; Weerapreeyakul N
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955600
[TBL] [Abstract][Full Text] [Related]
30. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation.
Quan L; Ohgaki R; Hara S; Okuda S; Wei L; Okanishi H; Nagamori S; Endou H; Kanai Y
J Exp Clin Cancer Res; 2020 Nov; 39(1):266. PubMed ID: 33256804
[TBL] [Abstract][Full Text] [Related]
31. Identification and functional characterization of a Na+-independent large neutral amino acid transporter, LAT1, in human and rabbit cornea.
Jain-Vakkalagadda B; Dey S; Pal D; Mitra AK
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2919-27. PubMed ID: 12824232
[TBL] [Abstract][Full Text] [Related]
32. BPA uptake does not correlate with LAT1 and Ki67 expressions in tumor samples (results of EORTC trial 11001).
Wittig A; Sheu-Grabellus SY; Collette L; Moss R; Brualla L; Sauerwein W
Appl Radiat Isot; 2011 Dec; 69(12):1807-12. PubMed ID: 21367608
[TBL] [Abstract][Full Text] [Related]
33. 5-(2-18F-fluoroethoxy)-L-tryptophan as a substrate of system L transport for tumor imaging by PET.
Krämer SD; Mu L; Müller A; Keller C; Kuznetsova OF; Schweinsberg C; Franck D; Müller C; Ross TL; Schibli R; Ametamey SM
J Nucl Med; 2012 Mar; 53(3):434-42. PubMed ID: 22331220
[TBL] [Abstract][Full Text] [Related]
34. The L-Type Amino Acid Transporter LAT1-An Emerging Target in Cancer.
Häfliger P; Charles RP
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100853
[TBL] [Abstract][Full Text] [Related]
35. L-type amino acid transporter 1, LAT1, in growth hormone-producing pituitary tumor cells.
Satou M; Wang J; Nakano-Tateno T; Teramachi M; Suzuki T; Hayashi K; Lamothe S; Hao Y; Kurata H; Sugimoto H; Chik C; Tateno T
Mol Cell Endocrinol; 2020 Sep; 515():110868. PubMed ID: 32579901
[TBL] [Abstract][Full Text] [Related]
36. A novel therapeutic approach for anaplastic thyroid cancer through inhibition of LAT1.
Enomoto K; Sato F; Tamagawa S; Gunduz M; Onoda N; Uchino S; Muragaki Y; Hotomi M
Sci Rep; 2019 Oct; 9(1):14616. PubMed ID: 31601917
[TBL] [Abstract][Full Text] [Related]
37. LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells.
Hayashi K; Jutabha P; Maeda S; Supak Y; Ouchi M; Endou H; Fujita T; Chida M; Anzai N
J Pharmacol Sci; 2016 Nov; 132(3):201-204. PubMed ID: 27567475
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma.
Ohshima Y; Kaira K; Yamaguchi A; Oriuchi N; Tominaga H; Nagamori S; Kanai Y; Yokobori T; Miyazaki T; Asao T; Tsushima Y; Kuwano H; Ishioka NS
Cancer Sci; 2016 Oct; 107(10):1499-1505. PubMed ID: 27465934
[TBL] [Abstract][Full Text] [Related]
39. p-[123I]iodo-L-phenylalanine for detection of pancreatic cancer: basic investigations of the uptake characteristics in primary human pancreatic tumour cells and evaluation in in vivo models of human pancreatic adenocarcinoma.
Samnick S; Romeike BF; Kubuschok B; Hellwig D; Amon M; Feiden W; Menger MD; Kirsch CM
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):532-41. PubMed ID: 14722685
[TBL] [Abstract][Full Text] [Related]
40. LAT1-Targeting Thermoresponsive Fluorescent Polymer Probes for Cancer Cell Imaging.
Matsuura M; Ohshima M; Hiruta Y; Nishimura T; Nagase K; Kanazawa H
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29865203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
